Omission of sentinel lymph node biopsy among women age 50-70 with early-stage breast cancer: applying an updated ASCO Guideline to a real-world population
- 6 July 2026
- journal article
- Published by Elsevier in Practical Radiation Oncology
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Cancer Institute (P30 CA015704)
- National Cancer Institute (K08 CA252640)
- National Cancer Institute (R25 CA112383)
This publication has 18 references indexed in Scilit:
- Implications of omitting sentinel lymph node biopsy on adjuvant decision making for patients with small breast cancersCancer, 2025
- Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: ASCO Guideline UpdateJournal of Clinical Oncology, 2025
- Axillary Surgery in Breast Cancer — Primary Results of the INSEMA TrialNew England Journal of Medicine, 2025
- Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph NodesJAMA Oncology, 2023
- Association Between Regional Nodal Irradiation and Breast Cancer Recurrence-Free Interval for Patients With Low-Risk, Node-Positive Breast CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2022
- Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast CancerJAMA Oncology, 2020
- Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trialThe Lancet, 2019
- Reducing Overtreatment of Cancer With Precision MedicineJAMA, 2018
- Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysisThe Lancet Oncology, 2013
- Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node MetastasisJAMA, 2011